EPISODE · Sep 19, 2025 · 29 MIN
Ozempic, Weight Cycling, and ARFID: The Risks of GLP-1s
from ANEW Insight · host Dr. Supatra Tovar
Send us Fan MailIn this episode of the ANEW Insight Podcast, Dr. Supatra Tovar and eating disorder expert Robyn Goldberg explore how the hype around GLP-1 weight loss medications like Ozempic connects to broader issues in health. While science advances on one end, everyday people are facing malnutrition, weight cycling, and disordered eating as they chase quick fixes.Robyn shares what she sees in her Beverly Hills practice: younger patients starting GLP-1s, hidden side effects like kidney stones, GI paralysis, and hair loss, and the deeper emotional toll of diet culture. Together, we discuss how to help clients navigate the risks of GLP-1s, break free from weight cycling, and reclaim a healthier relationship with food.Episode HighlightsWhy Ozempic and GLP-1s create malnutrition and energy crashesThe role of weight cycling in long-term weight gainFOMO, celebrity culture, and pressure from peers and doctorsHow ultra-processed foods hijack satiety and fuel cravingsNatural ways to support GLP-1 hormones through real food and meal timingARFID and picky eating: what it is and how to expand food choicesWhy compounding pharmacies and “gray market” injectables are riskyTimestamps00:00 – Introduction with Dr. Supatra Tovar and Robyn Goldberg 01:00 – The Ozempic era: side effects and misuse 04:00 – Malnutrition, fatigue, and hidden health costs 07:00 – Weight cycling and why dieting always rebounds 10:00 – Peer pressure, FOMO, and celebrity diet culture 14:00 – Compounding pharmacies and the underground drug market 18:00 – Supporting GLP-1 hormones naturally 21:00 – ARFID, picky eating, and strategies for variety 26:00 – Final reflections and how to find Robyn’s work📚 Resources & Links📖 Read my book Deprogram Diet Culture: Amazon Link📘 Read Robyn Goldberg’s book: The Eating Disorder Trap. . Here are her social media platforms links:https://askaboutfood.com/, https://www.yelp.com/biz/robyn-l-goldberg-rd-cedrd-los-angeles, https://share.google/W7x5rysYIFZLyxjTp , https://share.google/jetwJkPq3YENcA6IU 🎓 Join the Deprogram Diet Culture Course: anew-insight.com/deprogram-diet-culture 🎥 Watch this full episode on YouTube: ANEW Insight Podcast#ozempicsideeffects, #glp1drugs, #weightcycling, #arfid, #pickyeating, #dietculturetrap, #disorderedeating, #eatingdisorderrecovery,#drsupatratovar #drt #anewinsight #deprogramdietculture #nutrionalpsychology #anewinsightpodcast #robyngoldberg #intuitiveeating, #haes, #cleaneatingobsession, #malnutrition, #compoundingpharmacySupport the showThank you for joining us on this journey to wellness. Remember, the insights and advice shared on the ANEW Body Insight Podcast are for educational and informational purposes only and do not constitute medical advice. Always consult with a healthcare professional before making any changes to your health routine. To learn more about the podcast and stay updated on new episodes, visit ANEW Body Insight Podcast at anew-insight.com. To watch this episode on YouTube, visit @my.anew.insight. Follow us on social media at @my.anew.insight on Facebook, Instagram, TikTok, and Threads for more updates and insights. Thank you for tuning in! Stay connected with us for more empowering stories and expert guidance. Until next time, stay well and keep evolving with ANEW Body Insight!
Embed this episode
What this episode covers
Send us Fan Mail In this episode of the ANEW Insight Podcast, Dr. Supatra Tovar and eating disorder expert Robyn Goldberg explore how the hype around GLP-1 weight loss medications like Ozempic connects to broader issues in health. While science advances on one end, everyday people are facing malnutrition, weight cycling, and disordered eating as they chase quick fixes. Robyn shares what she sees in her Beverly Hills practice: younger patients starting GLP-1s, hidden side effects like kidney s...
NOW PLAYING
Ozempic, Weight Cycling, and ARFID: The Risks of GLP-1s
No transcript for this episode yet
Similar Episodes
No similar episodes found.